We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+23.07%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$6.14B
AUM Growth
+$2.32B
Cap. Flow
+$1.46B
Cap. Flow %
23.76%
Top 10 Hldgs %
63.49%
Holding
77
New
9
Increased
16
Reduced
14
Closed
12

Top Buys

Rank Stock Value
1
TLN
Talen Energy Corp
TLN
+$1.6B
2
VST icon
Vistra
VST
+$67.7M
3
UAL icon
United Airlines
UAL
+$51.5M
4
THS
Treehouse Foods
THS
+$45.4M
5
DK icon
Delek US
DK
+$42.3M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$65.8M
2
PLAY icon
Dave & Buster's
PLAY
+$48.8M
3
COOP
Mr. Cooper
COOP
+$42.8M
4
VYX icon
NCR Voyix
VYX
+$42.4M
5
COLL icon
Collegium Pharmaceutical
COLL
+$38.6M

Sector Composition

Rank Sector Weight
1 Utilities 39.48%
2 Healthcare 32.6%
3 Technology 5.2%
4 Industrials 5.14%
5 Energy 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLN
1
Talen Energy Corp
TLN
$16.7B
$2.03B 33.02%
+11,368,614
New +$1.6B
TEVA icon
2
Teva Pharmaceuticals
TEVA
$41.2B
$288M 4.7%
16,005,498
-1,256,243
-7% -$22M
ROIV icon
3
Roivant Sciences
ROIV
$26.2B
$258M 4.21%
22,400,000
-600,000
-3% -$6.83M
VST icon
4
Vistra
VST
$47.4B
$252M 4.1%
2,125,000
+797,894
+60% +$67.7M
GLNG icon
5
Golar LNG
GLNG
$5.13B
$240M 3.91%
6,535,062
– –
VTRS icon
6
Viatris
VTRS
$18.9B
$234M 3.81%
20,144,365
– –
QDEL icon
7
QuidelOrtho
QDEL
$838M
$192M 3.12%
4,200,000
+554,410
+15% +$22.4M
BGC icon
8
BGC Group
BGC
$4.89B
$156M 2.54%
16,972,580
-2,027,420
-11% -$18.9M
FLR icon
9
Fluor
FLR
$7.96B
$133M 2.16%
2,783,441
-431,080
-13% -$20.3M
LBTYA icon
10
Liberty Global Class A
LBTYA
$3.6B
$117M 1.9%
5,530,901
+4,794
+0.1% +$92.5K
ARQT icon
11
Arcutis Biotherapeutics
ARQT
$3.18B
$102M 1.66%
10,966,672
+1,150,000
+12% +$11.3M
MD icon
12
Pediatrix Medical
MD
$2.2B
$95.9M 1.56%
8,275,000
+125,000
+2% +$1.18M
COOP
13
DELISTED
Mr. Cooper
COOP
$95.5M 1.56%
1,035,998
-482,775
-32% -$42.8M
AMRX icon
14
Amneal Pharmaceuticals
AMRX
$5.79B
$89.2M 1.45%
10,721,778
– –
RNW icon
15
ReNew
RNW
$2.25B
$86.2M 1.4%
13,706,102
+200,000
+1% +$1.19M
ALIT icon
16
Alight
ALIT
$407M
$86.2M 1.4%
582,334
+161,181
+38% +$23.1M
DOLE icon
17
Dole
DOLE
$1.32B
$83.8M 1.36%
5,141,388
– –
LBTYK icon
18
Liberty Global Class C
LBTYK
$3.49B
$76.1M 1.24%
3,522,428
+11,424
+0.3% +$226K
ADPT icon
19
Adaptive Biotechnologies
ADPT
$3.97B
$73.7M 1.2%
14,400,000
+400,000
+3% +$1.74M
OPK icon
20
Opko Health
OPK
$1.02B
$72.6M 1.18%
48,706,640
+4,284,336
+10% +$6.36M
SDGR icon
21
Schrodinger
SDGR
$1.36B
$68.4M 1.11%
3,685,503
+555,503
+18% +$11.4M
MATV icon
22
Mativ Holdings
MATV
$711M
$68M 1.11%
4,000,000
– –
PTVE
23
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$65.9M 1.07%
5,726,583
– –
UAL icon
24
United Airlines
UAL
$42.1B
$63.5M 1.03%
+1,112,623
New +$51.5M
MREO
25
Mereo BioPharma
MREO
$47.3M
$62.9M 1.03%
15,307,347
– –
1
2 3 4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $9.55B AUM 31.94% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Rubric Capital Management (New York)'s Q3 2024 Portfolio in Review

As of Q3 2024, Rubric Capital Management (New York) held 77 positions worth $6.14B, up 61% from $3.81B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Rubric Capital Management (New York) deployed $1.46B of net new capital in Q3 2024, opening 9 new positions and adding to 16 existing holdings. Its largest new stake was Talen Energy Corp: 11,368,614 shares worth $2.03B.

By sector, the portfolio is most concentrated in Utilities at 39% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Mr. Cooper, an estimated $42.8M trimmed.

  • Rubric Capital Management (New York)'s largest Q3 2024 buy was Talen Energy Corp: 11,368,614 shares worth $2.03B.
  • Rubric Capital Management (New York) added most to Vistra in Q3 2024, an estimated $67.7M increase.
  • Rubric Capital Management (New York)'s biggest Q3 2024 reduction was Mr. Cooper, cutting an estimated $42.8M.
  • Rubric Capital Management (New York) fully exited Jazz Pharmaceuticals in Q3 2024, selling an estimated $65.8M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 63% of its $6.14B portfolio in Q3 2024.
  • Rubric Capital Management (New York) opened 9 new positions and closed 12 in Q3 2024.
  • Rubric Capital Management (New York)'s portfolio value rose 61% quarter-over-quarter to $6.14B.

Based on Rubric Capital Management (New York)'s 13F filing for Q3 2024, filed 13 Nov 2024.